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Healthy tissues surrounding abdomino-pelvic tumours can be impaired by radiotherapy, leading to
chronic gastrointestinal complications with substantial mortality. Adipose-derived Mesenchymal Stro-
mal Cells (Ad-MSCs) represent a promising strategy to reduce intestinal lesions. However, systemic
administration of Ad-MSCs results in low cell engraftment within the injured tissue. Biomaterials, able to
encapsulate and withstand Ad-MSCs, can overcome these limitations. A silanized hydroxypropylmethyl
cellulose (Si-HPMC) hydrogel has been designed and characterized for injectable cell delivery using the
operative catheter of a colonoscope. We demonstrated that hydrogel loaded-Ad-MSCs were viable, able
to secrete trophic factors and responsive to the inﬂammatory environment. In a rat model of radiation-
induced severe colonic damage, Ad-MSC þ Si-HPMC improve colonic epithelial structure and hyper-
permeability compared with Ad-MSCs injected intravenously or locally. This therapeutic beneﬁt is
associated with greater engraftment of Si-HPMC-embedded Ad-MSCs in the irradiated colonic mucosa.
Moreover, macrophage inﬁltration near the injection site was less pronounced when Ad-MSCs were
embedded in the hydrogel. Si-HPMC induces modulation of chemoattractant secretion by Ad-MSCs that
could contribute to the decrease in macrophage inﬁltrate. Si-HPMC is suitable for cell delivery by co-
lonoscopy and induces protection of Ad-MSCs in the tissue potentiating their therapeutic effect and
could be proposed to patients suffering from colon diseases.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Radiotherapy plays a crucial in the management of malignant
pelvic diseases. However, the major limitation of this treatment is
its toxicity on surrounding healthy tissues such as the small in-
testine, colon and rectum. Due to the high proliferative capacity of
epithelial stem cells located at the base of the crypts, the gut is anchymal Stromal Cells; Si-
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u).
Ltd. This is an open access article uvery radiosensitive organ. Irradiation produces free radicals that,
through direct and indirect effects, induce crypt cell apoptosis
leading to mucosal lesions with a loss of epithelial barrier function.
The intestinal epithelial barrier is maintained by intracellular
junctional complexes, such as tight junctions (TJs), adherent junc-
tions and desmosomes. Irradiation increases mucosal permeability,
inducing nutrient and ﬂuid loss as well as gut pathogen inﬁltration,
exacerbating mucosal inﬂammation [1]. This inﬂammatory state,
combined with the deﬁciency of epithelial stem cells and local
ischemia, leads to a defective healing process which can result in
tissue loss (ulceration) or pathological healing (ﬁbrosis, ﬁstula) [2].
Patients (10e20%) undergoing radiotherapy for abdominal
cancers develop intestinal complications several years after the endnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
L. Moussa et al. / Biomaterials 115 (2017) 40e52 41of their treatment. These chronic complications adversely affect
quality of life and, in some cases, can be life-threatening. Man-
agement of patients suffering from radiotherapy-related gastroin-
testinal disorders is limited to symptomatic treatments. No curative
treatments are currently available. Therefore, symptoms reoccur
once treatment is stopped and new features may arise depending
upon the course of the disease. The lack of curative treatment and
the potential severity of the gastrointestinal disorders highlight the
importance of ﬁnding a novel and effective treatment. Stem cell-
based regenerative medicine using mesenchymal stromal cells
(MSCs) is considered a promising approach, as suggested by
encouraging results from various clinical trials [1].
Convincing experimental results from different animal models
[3e5] and in clinical cases treated on a compassionate basis [6,7]
have shown that intravenous (IV) injection of MSCs reduces se-
vere colorectal lesions caused by ionizing irradiation. Experiments
performed on animal models have shown that IV-MSC treatment
promotes epithelial regeneration leading to intestinal structure
improvement and limiting the ﬁbrosis process [3e5]. The beneﬁcial
effects of MSC injection have been primarily related to their
secretion of a wide variety of bioactive molecules [8]. MSCs secrete
angiogenic, pro-regenerative, anti-apoptotic and immunosuppres-
sive factors that may contribute to intestinal ulcer wound healing.
Moreover, pre-clinical data on mini-pigs has demonstrated that
repeated intravenous MSC injections are necessary to improve
radio-induced colorectal ulcer healing [9]. These data suggest that
MSC-induced therapeutic beneﬁt requires a large number of
injected cells. Despite a large amount of MSCs being systemically
injected, very low cell engraftment in the irradiated intestine has
been reported [3,4]. Indeed, studies have demonstrated that sys-
temically injected MSCs were trapped in the lung after infusion
[10]. Although a study from Prockop group has demonstrated that
the anti-inﬂammatory effects of MSCs depend upon their trapping
in the lung [11], some studies have demonstrated a pulmonary
embolus following intravenous injection of MSCs [12e14]. It is
known that MSCs are short-lived when infused intravenously.
Indeed, they die within 24 h and are cleared from the body [15].
Thus, local injection of cells has been tested according to the
accessibility of the tissue [16]. This injection method allows fewer
cells to be injected, increases the rate of MSC engraftment in the
area requiring repair and interestingly, for clinical application, re-
duces the cost of the treatment. Moreover, local injection reduces
the spread of stem cells throughout the body, although no side
effects have been shown after either local or intravenous injection
of MSCs [17,18]. While local injection leads to better cell engraft-
ment, cell viability could be limited due to the host microenvi-
ronment, particularly in the case of radiotherapy. After colorectal
irradiation, the secretion of pro-inﬂammatory cytokines as IL1b,
TGFb and chemoattractant has been demonstrated, as well as the
huge inﬁltrate of innate immune cells [19,20]. In order to overcome
these drawbacks, the use of a hydrogel that entraps the MSCs may
protect the cells from the host tissue environment. The cytopro-
tective properties of the hydrogel could maintain the viability and
function of the cells. This biomaterial-assisted cell therapy may
make it possible to signiﬁcantly increase the therapeutic beneﬁt
with a reduced number of injections. Indeed, in cases of ischemia
(heart and hindlimb), studies have demonstrated that injection of
MSCs embedded in biomaterials enhances their therapeutic beneﬁt
[21,22]. This method of injection is also used for articular cartilage
repair by direct implantation with minimally invasive surgery [23].
Amongst the wide variety of biomaterials, biocompatible
hydrogels may represent an excellent cell delivery system in view
of their distinctive property of permitting in-situ gelation. Two
types of hydrogels exist: natural and synthetic. Natural hydrogels
are used as scaffolds because they display numerous biologicalfunctions that synthetic polymers lack, such as cell adhesion and
biodegradation. A hybrid semi-synthetic, semi-biological silanized
hydroxypropylmethyl cellulose (Si-HPMC) hydrogel has been
designed as an injectable cell carrier. This Si-HPMC hydrogel is
biocompatible, able to self-crosslink in situ to form a scaffold and
maintain MSC phenotype, viability and secretion ability [23].
Indeed, Mathieu et al. have demonstrated the beneﬁcial effect of Si-
HPMC hydrogel in cardiac tissue engineering with a pronounced
improvement in cardiac capacity after infarction when MSCs were
injected within the biomaterial [22].
Here, we aimed to use a Si-HPMC hydrogel with rheological
properties compatible with clinical use through a speciﬁc colono-
scope catheter. We evaluated the effects of hydrogel-assisted Ad-
MSC therapy comparedwith conventional intravenous injections of
MSCs as used in clinical applications on structural and functional
damage induced on a rat model of colorectal irradiation [4]. We also
followed the engraftment of the Ad-MSCs and their fate in the
lesion site. Lastly, we studied the hydrogel's ability to protect the
cells from the deleterious irradiated environment.
2. Materials and methods
2.1. Ethics statement
All experiments were performed in compliance with the Guide
for the Care and Use of Laboratory Animals as published by the
French regulations for animal experiments (Ministry of Agriculture
Order No. B92-032-01, 2006) with European Directives (86/609/
CEE) and were approved by local ethical committee of the institute
(permit number P13-14).
2.2. Animals and irradiation protocol
Male SD (Sprague Dawley, non-consanguineous) rats (Janvier
SA, Le Genest St Isle, France) weighing 250 g were received and
housed in a temperature-controlled room (21 ± 1 C). They were
allowed free access to water and fed standard pellets. Rats were
anesthetized by isoﬂurane inhalation and a single 29 Gray (Gy)
dose was delivered by a medical accelerator (Alphee) through a
2  3 cm window centered on the colorectal region. Alphee is an
accelerator-type radiation source (maximal energy is 4 MeV with
an average energy of about 1.5 MeV; 30 kA).
2.3. Cell culture and characterization
Adipose-derived MSCs were obtained by digesting the subcu-
taneous inguinal adipose tissue of seven-week-old GFP-transgenic
SD rats as previously described [5]. After 7 days, the monolayer of
adherent cells was trypsinized, washed in PBS three times before
injection in rats. The phenotype of ampliﬁed Ad-MSC was veriﬁed
by ﬂow cytometry. The percentage of CD90 (clone OX-7; BD Bio-
sciences, Le pont de Claix, France) and CD73 (clone 5F/B9; BD
Biosciences) positive cells were analyzed and the absence of he-
matopoietic cells was veriﬁed with CD34 (clone ICO115, Santa Cruz,
Dallas, Texas, USA) and CD45 (clone OX-1; BD Biosciences) markers.
Isotype identical antibodies served as controls. On average, Ad-MSC
expressed CD90 at 95.25% (±2.7), CD73 at 65.42% (±18.9), CD34 at
1.45% (±1.01) and CD45 at 0.575% (±0.2). The potential of adipo-
genic and osteogenic differentiations was also evaluated.
2.4. Hydrogel preparation
Hydroxypropyl methyl cellulose (Methocel® E4M Premium
procured from Colorcon) was silanized by grafting 3-
glycidoxypropyltrimethoxysilane GPTMS as previously described
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dialyzed to reach a ﬁnal pH value of 12.7 [25]. Acidic buffer solution
used to neutralize the basic Si-HPMC solution was prepared using
0.1 M HCl and HEPES as previously described [25]. Si-HPMC
hydrogels were prepared by rapidly mixing the polymer and the
buffer at a ratio of 2:1 leading to a pH of 7.4 and then, initiating
silanol condensation.
2.5. Injectability of the hydrogel
The injectability was measured using a compression testing
device (TAHDplus) with 5 kg load cell utilized for the measure-
ments. Five kg is the maximum force that can be applied by hand.
Si-HPMC at either concentrations of 1% and 1.5% were pre-loaded
into the catheter. A syringe containing 1 ml 0.1 M NaCl (Sigma-
Aldrich, Germany) was attached to the catheter and the injection
force was measured.
2.6. Rheological characteristics
2.6.1. Viscosity
Intrinsic viscosity was measured using a steady shear rate
ranging from 0.1 to 100 s1 at room temperature. The subsequent
ﬂow curves were ﬁtted using the simpliﬁed Cross equation for each
of the Si-HPMC concentrations measured to calculate the limiting
viscosity [26].
2.6.2. Gel point measurements
The gel point was measured on HAAKE RheoStress RS300
rheometer (Thermo Scientiﬁc) using cone/plate geometry (1/
60 mm). Liquid hydrogel precursor solutions were injected on the
plate immediately after mixing and the measurements started
1e2 min later. Storage (G') modulus was monitored as a function of
time under oscillation frequency sweep (from 1 to 22 Hz) at a
constant temperature (23 C). The gel point was determined when
tan d ¼ G00/G0 became independent from frequency. Each sample
was measured in triplicate.
2.6.3. Elastic modulus measurements
Storage (G0) modulus of fully cross-linked hydrogels was
measured using a plate geometry (PP20 Ti) under oscillatory mode
with a shear stress ranging from 0.1 to 3000 Pa. Initially,1% and 1.5%
(w/v) Si-HPMC was formulated and poured (2 mL) into 12-well
plates. Plates were placed either at room temperature or a 37 C
incubator under a humid atmosphere to prevent drying and
allowed to set for 14 days. Plate was loaded onto a specially
designed plate platform for the rheometery measurement and then
a 0.5 N normal force was applied prior to measurement. G0 for Si-
HPMC at each concentration was determined from the graphs.
2.7. Ad-MSC viability, morphology and proliferation within the
hydrogel
Cells were seeded at 3.33 106 cells/ml with each individual gel
containing approximately 1  106 cells. Cell viability was evaluated
using Calcein AM-ethidium homodimer assay (Live and Dead®,
Invitrogen, France) and then observed using a confocal microscope.
Images were then assessed using commercial software (Velocity,
Nikon corporation) to count the number of green (live) and red
(dead) cells from each sample. Samples stained yellow (dual
stained red and green) upon analysis were counted as dead cells.
Cells were cultured for a 21 day period with live/dead assessment
conducted on day 1, 7, 14 and 21 during culture. A set of cells was
cultured in the presence of actinomycin D (10 mg/ml) to act as a
negative control for the study. Proliferation analyses were realizedusing immunoﬂuorescence. Cells were loaded on the lab-Tek
chamber slide system (Nunc) with or without hydrogel during
72 h in culture medium. After PBS 1X washing, the cells were ﬁxed
then permeabilized with TritonX-100 0.5% during 15min and
incubated overnight with mouse anti PCNA (M0879, DakoCyto-
mation). Staining was revealed using a ﬂuorescent secondary
antibody (1/200eme goat anti-mouse Alexa 488, A11017, Invi-
trogen). After washing, nuclei were stainedwith DAPI (Vector Labs).
2.8. Experimental protocol
In two series of experiments, 3 weeks after irradiation, rats were
injected with either 5.106 or 1.106 Ad-MSCs intravenously (IV) or
1.106 Ad-MSCs locally injected with or without Si-HPMC (at 1 or
1.5% of concentration) using a colonoscope (Pentax, Argenteuil,
France) (see video). For IV injection, 5.106 or 1.106 of Ad-MSCs were
diluted in 500 ml of PBS and injected in the tail vein. For local in-
jection, 1.106 of Ad-MSCs was mixed with 300 ml of Si-HPMC (1 or
1.5%) and injected locally using the colonoscope (Supplementary
Fig. A,D). A single injector use (Olympus, Rungis, France) of
165 cm of length and 2 mm of diameter connected to a needle (23
Gauge) was used. Two injection points were done, upstream and
downstream of the lesion (Supplementary Fig. B,C). Animals were
then sacriﬁced one week later. In the ﬁrst series, distal colons were
dissected, washed in Krebs solution and used for colonic epithelial
permeability measurements in Ussing chambers. A second series of
experiments was performedwhere samples of colonwere collected
for claudin 4 expression by Western blot and for histological and
immunohistochemistry staining.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2016.11.017.
2.9. Ussing chambers experiments
Immediately after the sacriﬁce, distal colons were removed, cut
along the mesenteric border, and three colonic strips from each rat
were mounted in Ussing chambers (Corning Costar Corporation,
Harvard Apparatus, France) having a ﬂux area of 0.1 cm2. Colonic
epithelial permeability to small and large molecules was measured
through the mucosal-to-serosal passage of ﬂuoro isothiocyanate
(FITC)-Dextran 4 kDa (FD4) and intact Horseradish peroxidase
(HRP) 44 kDa (Sigma-Aldrich, Saint Quentin Fallavier, France),
respectively, added simultaneously in the mucosal compartment.
After 20 min of equilibration, 600 ml of buffer solution on the
mucosal side was replaced by 300 ml of FD4 (2.2 mg/ml, Sigma-
Aldrich) and 300 ml of HRP (0.4 mg/ml, Sigma-Aldrich). Electrical
parameters, including potential difference, short-circuit current
(Isc) and total electrical resistance (R), were recorded at regular
intervals during the 2-h period of experimentation. Colonic
permeability to FD4 was determined by measuring the ﬂuores-
cence intensity at 485 nm/525 nm using an automatic Inﬁnite
M200 microplate reader (Tecan, Lyon, France). Epithelial perme-
ability to intact HRP was determined by an enzymatic assay [27] for
speciﬁc HRP activity found in the serosal and mucosal compart-
ment using a microplate reader (Tecan). Permeability was calcu-
lated as the ratio of ﬂux/concentration, as previously described [28]
and expressed in cm/second.
2.10. Tissue protein extraction and claudin 4 expression by western
blot
Tissue proteins were extracted with RIPA buffer (Santa Cruz,
Dallas, Texas, USA) with protease inhibitor cocktail (Roche Di-
agnostics, Meylan, France). Clear lysates were prepared by centri-
fugation at 10000g for 10 min, and protein concentrations were
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Equal protein amounts of each extract were separated in 12.5%
SDS-polyacrylamide gel and transferred onto 0.45 mm nitrocellu-
lose membranes (Whatman). Membranes were blocked with 5%
dry milk in 0.1% tween in PBS (PBST) for 45 min at RT, and then
incubated overnight at 4 C with either mouse anti-claudin 4
antibody (Life Technologies, Saint-Aubin, France; 1/500) or anti-
GAPDH antibody used as internal standard. After washing in
PBSTemilk, membranes were incubated for 1 h at RT with horse-
radish peroxidase-conjugated secondary antibody (Amersham ECL
Kit; 1/5000) and washed. Bands were identiﬁed using Luinata Forte
substrate (Merc Millipore, Darmstadt, Germany). Relative values of
the band density were estimated using ImageJ software (NIH,
Bethesda, MD, USA) and claudin 4 expression was assessed relative
to GAPDH for each sample analyzed.
2.11. Histological and lesion analyzes
Animals were sacriﬁced and immediately after, the irradiated
area which corresponds to a white, non-vascularized zone was
measured (photos were taken with Zeiss binocular (x 0.6)). Then,
the colon was collected and ﬁxed in 4% formaldehyde and
embedded in parafﬁn. Parafﬁn embedded colons were cut on a
rotary microtome (Leica Microsystems AG, Wetzlar, Germany) into
serial circular sections of 5 mm, spaced 150 mm (all damaged zone)
and stained with hematoxylin-eosin-saffron (HES). The severity of
colorectal damage induced by irradiation was assessed using an
injury score. Determination of the injury score was based on
mucosal damages (ulceration, epithelial atypia, and regenerative
crypts), edema, colitis cystica profunda, vascular sclerosis and
muscular dystrophy. Graduation of the injury was 0 ¼ null;
10 ¼ slight; 20 ¼ moderate and 30 ¼ severe.
2.12. Immunohistochemistry
For immunohistochemistry (IHC), sections were deparafﬁnized
and hydrated. Serial slides were used for GFP, PCNA and CD68
staining. Tissue sections were treated with 0.1% triton X-100
(Sigma-Aldrich) in PBS 1x (Life Technologies) at room temperature
(RT) for 10 min. Then endogenous peroxidases were inhibited by
incubation with 3% H2O2 in methanol at RT for 10 min. For GFP
(Green Fluorescent Protein) IHC, after saturation (X0909, DakoCy-
tomation, Courtaboeuf, France), goat anti-GFP diluted to 1/1000
(ab6673, Abcam, Cambridge, UK) was applied for 1 h at 37 C.
Sections were incubated with impress reagent kit anti-goat Ig
(MP7405, Vector) for 20 min at RT. For CD68 IHC, enzymatic
retrieval solution (Proteinase K, S3020, DakoCytomation) was per-
formed. After saturation, mouse anti rat CD68 (MCA341R, AbDser-
otec, Oxford, UK) at 1 mg/mL was applied for 1 h at 37 C. Sections
were incubated with Envision kit anti-mouse HRP (K4002, Dako-
Cytomation) for 30 min at RT. For PCNA (Proliferating Cell Nuclear
Antigen) immunostaining, tissue sections were placed in an anti-
gen retrieval solution (0.01 M citrate buffer, pH ¼ 6 (DakoCyto-
mation) for 15 min at 350 W) and quenched for endogenous
peroxidases as described above. After saturation, mouse anti PCNA
(M0879, DakoCytomation) at 525 mg/ml was applied for 1 h atTable 1
Formulation and characterization of Si-HPMC for colonoscopy procedure. Viscosity, in
vs. 1% Si-HPMC, bp < 0.05 vs. RT, RT ¼ Room Temperature.
Si-HPMC concentration (%) Viscosity (Pas) Injectability (kg)
1 0.086 ± 0.016 1.34 ± 0.07
1.5 0.309 ± 0.05a 3.52 ± 0.1a37 C. Sections were incubated with Envision kit anti-mouse HRP
for 30 min at RT.
Staining was developed with Histogreen substrate (E109,
Eurobio, Les Ulis, France). Then, sections were counterstained with
nuclear fast red (H3403, VectorLabs, Burlingame, CA, USA), dehy-
drated and mounted. Isotype control antibodies are used as nega-
tive controls.
2.13. Double staining of GFP and TUNEL
In order to identify if Ad-MSC expressing GFP are apoptotic,
double staining of GFP and terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL) was performed.
Following immunohistochemical staining of GFP, as described
above (using donkey anti-goat Alexa as secondary antibody), the
TUNEL was performed using the In Situ Cell Death Detection Kit
(Roche Diagnostics).
2.14. Secretome analysis
Proteins released from Ad-MSCs during culture in 2D and 3D
were quantiﬁed following 7 days of culture. On day 6, culturemedia
was aspirated and cells washed using PBS. Medium without serum
was added to the cells and then incubated for 24 h. Media was then
evaluated for secretome products using commercial rat ELISA kits.
Data normalization for the secreted factors required DNA quanti-
ﬁcation using Picrogreen dsDNA quantiﬁcation kit (Invitrogen).
2.15. Statistical analysis
All data are presented as mean ± SEM. Statistical analyzes were
performed using Graph Pad Prism 5.0 (GraphPad, San Diego, CA).
Statistical signiﬁcance was determined using one-way ANOVA
followed by Tukey's post-test for multiple groups, or two-way
ANOVA followed by Bonferroni's post-test for multiple groups
with different variables, or t-test when changes were compared
between two groups. Statistical signiﬁcance was set at p < 0.05.
3. Results
3.1. Formulation and characterization of Si-HPMC for colonoscopy
procedure
Local treatment for colorectal side effects of radiotherapy can be
administered using the operative channel of a colonoscope. Our
aim was to determine the appropriate Si-HPMC concentration that
provides the best compromise between the injectability within the
speciﬁc catheter system and optimized cell protection. Si-HPMC
viscosity was measured using a rheometer under a variable shear
stress. Two Si-HPMCs at ﬁnal concentrations of 1% and 1.5% (w/v)
were tested before cross-linking, and measurements showed an
increase in viscosity with Si-HPMC concentration (Table 1). The
results showed that, in these conditions, the peak force applied was
1.34 kg for 1% Si-HPMC and 3.52 kg for 1.5% Si-HPMC concentra-
tions (Table 1). These results therefore determined that both Si-
HPMC concentrations could be injected through the colonoscopejectability, gel-point and elastic modulus of Si-HPMC at 1% and 1.5%. N ¼ 3. ap<0.05
Gel point (min) Elastic modulus (Pa)
RT 37 C RT 37 C
56.5 ± 2.6 19.4 ± 1.3b 145 ± 40.6 130.2 ± 20.7
41.5 ± 5.9 11.9 ± 1.5b 426.8 ± 53.4a 380.9 ± 58.2a
Fig. 1. In vitro cell viability, morphology and secretome analysis within Si-HPMC. (A) Cell viability was evaluated using Live and Dead assay. Live cells are in green and dead ones
are in red. Cells stained in yellow (dual stained red and green) upon analysis were counted as dead cells. (B) Morphology of GFP-Ad-MSC in 2D or 1% and 1.5% hydrogel. (C) In vitro
proliferation analyses of Ad-MSCs in 2D and in hydrogel with different levels of stiffness. Representative pictures of immunoﬂuorescence staining. Proliferative cells were stained
with PCNA marker in green and all the nuclei were stained with dapi in blue. Most of Ad-MSCs were proliferative in 2D (left) and none in 3D whatever the concentration of the
hydrogel (middle and right). (D) Secretion factors in supernatants of Ad-MSCs in Si-HPMC compared with two-dimensional Ad-MSCs. Data normalization for the secreted factors
required DNA quantiﬁcation using Picrogreen dsDNA quantiﬁcation kit. N ¼ 3 donors in triplicate. *p < 0.05 vs. 2D, **p < 0.01 vs. 2D.
L. Moussa et al. / Biomaterials 115 (2017) 40e52 45catheter. Table 1 shows that with respect to temperature, the gel-
point signiﬁcantly decreased at body temperature (37 C)
compared to room temperature (21 C) at both Si-HPMC concen-
trations (p < 0.05). A reduction in the Si-HPMC concentration
resulted in an increase in the gel-point, whereby a positive corre-
lation between Si-HPMC concentration and gelation time was
found at both temperatures measured (p < 0.05). Moreover, a sig-
niﬁcant difference between Si-HPMC concentrations was found in
terms of elastic modulus (G') with a lower value for 1% Si-HPMC
compared to 1.5%, when no difference was observed between
room and body temperature. However, both values are compatible
with soft tissue (i.e. colon) application. Taken together, these ana-
lyses determined that 1% and 1.5% Si-HPMC hydrogel have the
required properties: Si-HPMC viscosity enables it to be injected at
1% and 1.5% with the colonoscope. Its reticulation kinetic at room
temperature is compatible with manipulation by the surgeons in
the operating theatre. Moreover, once injected in vivo (37 C), the
mechanical properties of the Si-HPMC were not modiﬁed and the
reticulation time is fast (12e19 min) ensuring optimal cell
protection.
3.2. Viability, morphology and secretome analyses of Ad-MSCs
embedded in Si-HPMC
The viability of Ad-MSCs in 1% and 1.5% hydrogel has been testedFig. 2. Characterization of radiation-induced epithelium damage 4 weeks after irradiatio
In a normal non-irradiated colon (top left picture), organized crypts were observed. In the reg
atypical zone, we distinguished atypical, disorganized crypts and small edema (bottom left
dense inﬂammatory inﬁltrate (bottom right picture). The sub-mucosa was characterized by
Percentage of slides in each area (regenerative, atypical and ulcerated area). N ¼ 10 animals p
Reg ¼ regenerative, Aty ¼ atypical, Ulc ¼ ulcerated. #p < 0.05 vs. irradiated rats, ##p < 0.0in vitro for 21 days. When Ad-MSCs were mixed in 1% Si-HPMC, we
observed that not all the cells were entrapped and some cells
remained attached to the bottom of the culture plate (data not
shown). Cells mixed with a 1.5% Si-HPMC concentration appeared
to be fully entrapped within the hydrogel, thus viability and cyto-
kine release were only assessed for this condition. We quantiﬁed
that 95% of cells were viable after 21 days of culture (Fig. 1A).
Morphology of Ad-MSCs embedded in Si-HPMC has been assessed:
we observed that cells in 3D have a spherical morphology which is
not modiﬁed with the stiffness of the hydrogel (Fig. 1B). We
observed, in the viability experiments, that the number of cells is
not modiﬁed with time. To verify the lack of proliferation in the
hydrogel, we used PCNA (Proliferating Cell Nuclear Antigen) im-
munostaining, and conﬁrmed that Ad-MSCs in Si-HPMC do not
proliferate whatever the stiffness of the hydrogel (Fig. 1C). Since it
has been established that the therapeutic beneﬁt of MSC-based
therapy is associated with their capacity to secrete a broad range
of bioactive molecules, we tested the ability of Ad-MSCs embedded
in 1.5% Si-HPMC (3D) to secrete growth factors involved in
epithelial regeneration (IGF1-2, KGF, IL11, EGF and FGF2), pro-
angiogenesis (VEGF) and anti-inﬂammatory processes (PGE2 and
IL10), compared with Ad-MSCs cultivated in a monolayer (2D). To
normalize the quantity of secreted molecules according to cell
number, all the results were expressed according with DNA con-
tent. We demonstrated that Ad-MSCs mixed in the hydrogel keptn. (A) Representative pictures of the lesion score used. Arrows represent colonic crypts.
enerative zone, regenerative, elongated crypts were observed (top right picture). In the
picture). In the ulcerated zone, crypts were totally absent and mucosa was replaced by
an immense edema with dense extracellular matrix deposition. (B) Lesion score. (C)
er group. IR ¼ irradiated rats, M ¼million, IV ¼ intravenous, loc ¼ locally injected cells,
1 vs. irradiated rats.
Fig. 3. Effects of biomaterial-assisted Ad-MSCs on radiation-induced changes in
colonic permeability. (A) Schematic diagram of colonic epithelial barrier in physio-
logical condition. Arrows indicate the passage of two molecules (FD4 and HRP)
through epithelial cells (in pink). (BeC) Measurement of colonic permeability to FD4
and HRP using Ussing Chambers. (D) Western Blotting for claudin-4 expression.
Western Blotting on colonic protein extracts was realized using claudin-4 antibody and
GAPDH as internal control. Representative western blot of each group (upper) and
graph representing the quantiﬁcation of Claudin-4 expression after GAPDH normali-
zation (lower). N ¼ 16 animals per group for colonic permeability analyses and N ¼ 6
animals per group for Western Blotting analysis. IR ¼ irradiated rats, M ¼ million,
IV ¼ intravenous, loc ¼ locally injected cells. *p < 0.05 vs. non-irradiated rats, **p < 0.01
vs. non-irradiated rats, #p < 0.05 vs. irradiated rats.
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embedded in 1.5% Si-HPMC were able to secrete higher concen-
trations of IGF-1 and PGE2 compared to Ad-MSCs in 2D.
3.3. The therapeutic beneﬁt of Si-HPMC-assisted cell therapy on
colonic epithelial structure
To determine the Ad-MSC treatment procedure that produces
the greatest therapeutic beneﬁt, we initiated in vivo experiments
using the procedure described in section 2.8 (supplementary
ﬁgure) and the histological structure of the colon was initially
assessed. To analyze the improvement in the colonic structure, two
quantiﬁcations were performed. In the ﬁrst, we quantiﬁed the
severity of the lesion (lesional score Fig. 2A and B) and in the second
we measured the extent of the damage (Fig. 2C). Histological sec-
tions of normal colon showed organized crypts. In the irradiated
ﬁeld, three zones were differentiated according to epithelial pa-
rameters: the ulcerated, atypical and regenerative areas (Fig. 2A).
The therapeutic effect of the treatments on epithelial injury was
assessed in the various zones separately. In the regenerative and
atypical zones, we noted that 5  106 of IV-injected Ad-MSCs and
1  106 of locally-injected Ad-MSCs in 1.5% hydrogel induced a
signiﬁcant reduction in the epithelial injury score one week after
treatment (p < 0.05) (Fig. 2B).
Quantiﬁcation of the number of ulcerated, atypical and regen-
erative slides was performed. We observed that the number of
ulcerated slides was decreased (p ¼ 0.034) in rats treated with 1.5%
Ad-MSC þ Si-HPMC compared with irradiated animals. Moreover,
this latter treatment signiﬁcantly increased the number of regen-
erative slides in comparison with irradiated animals (p < 0.05)
(Fig. 2C). Overall, these results demonstrate that locally-injected
Ad-MSCs embedded within 1.5% Si-HPMC induce a signiﬁcant
reduction in radiation-induced colonic epithelial damage as
compared to Ad-MSCs injected intravenously or locally alone. These
data also suggest that Ad-MSCs embedded in 1.5% Si-HPMC in-
crease the regenerative process in the margins of the lesion leading
to a reduction in the ulcerated area.
3.4. The therapeutic beneﬁt of Si-HPMC-assisted cell therapy on
epithelial barrier function
Intestinal permeability is one of the primordial functions of the
gut epithelium and is commonly used as a marker of epithelial
integrity. The colonic epithelium forms a selective barrier which
prevents the penetration of luminal content (Fig. 3A). Epithelial
barrier function was assessed in our experimental rat model, using
the system of Ussing Chambers measuring colonic permeability to
FD4 and intact HRP. Colonic irradiation induced an increase in
colonic permeability to FD4 compared with control rats,
(0.51673 cm/s vs. 0.926619 cm/s respectively) (Fig. 3B). Intravenous
injection of Ad-MSCs did not modify colonic hyperpermeability to
FD4 induced after irradiation. Locally-injected Ad-MSCs combined
with 1.5% Si-HPMC signiﬁcantly decreased colonic hyper-
permeability to FD4 induced after irradiation (Fig. 3B). Colonic
irradiation also induced a signiﬁcant increase in colonic perme-
ability to intact HRP in comparisonwith controls (Fig. 3C, p < 0.05).
A signiﬁcant effect on epithelial hyperpermeability to intact HRP
was observed in rats treated with Ad-MSCs embedded within
hydrogel at both concentrations (Fig. 3C). However, Ad-MSCs
injected intravenously did not restore signiﬁcantly HRP perme-
ability to control level. It should be noted, however, that neither 1%
nor 1.5% Si-HPMC injected alone had a beneﬁcial effect on
radiation-induced hyperpermeability to FD4 or HRP (Fig. 3B and C).
The colonic epithelial barrier is maintained by intercellular
junctional complexes, such as Tight-Junctions (TJs) (Fig. 3A). TJs arecomposed of transmembrane proteins including claudin-4 amongst
others. Western blotting experiments demonstrated a decrease in
claudin-4 expression after colorectal irradiation compared with
non-irradiated rats. In accordance with FD4 permeability
Fig. 4. Ad-MSC engraftment in colonic sub-mucosa after injection. (A) Represen-
tative pictures of GFP-Ad-MSCs after IHC (in blue) in the irradiated colonic sub-mucosa
7 days after local injection of GFP-Ad-MSCs (left) or GFP-Ad-MSCs embedded in 1.5%
hydrogel (right). (B) Quantiﬁcation of the GFP-Ad-MSCs engraftment. The extent of
GFP-Ad-MSCs engraftment in the irradiated colon is quantiﬁed by the percentage of
slides GFP-Ad-MSC-positive cells among the total of analyzed slides (left). The quantity
of GFP-Ad-MSCs engrafted cells was also quantiﬁed using histolab software. On the
GFP positive slides, the surface of GFP staining is evaluated among 10 000 mm2 of tissue
surface (right). (C) Later time point engraftment analyses of locally injected Ad-MSCs in
1.5% hydrogel. Representative pictures of GFP-Ad-MSCs after IHC (in blue) in the
irradiated colonic sub-mucosa 14 days (left) and 21 days. N ¼ 8 animals per group.
IR ¼ irradiated rats, M ¼million, loc ¼ locally injected cells. xp < 0.05 vs. irradiated rats
locally injected with Ad-MSCs without hydrogel.
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whereas local treatment with Ad-MSCþ 1.5% Si-HPMC reversed the
effect of irradiation on claudin-4 expression (Fig. 3D).
3.5. Potentiation of Ad-MSC engraftment in the colonic mucosa by
1.5% Si-HPMC
To localize Ad-MSCs in the host tissue, cells were prepared from
the adipose tissue of GFP-transgenic SD rats before IV or local in-
jection into irradiated SD rats. We then analyzed Ad-MSC engraft-
ment on colonic sections taken every 150 mm throughout the distal
colon. A previous study had revealed the presence of some GFP cells
in the mesentery near the vessels and in the submucosa, one week
after irradiation and IV injection of MSCs [4]. Here, the number of
slides with Ad-MSC GFP-positive cells was counted in each of the
treated groups. In this study, Ad-MSCs were injected into estab-
lished damage (3 weeks) and no GFP-positive cells could be
detected in the irradiated colonic mucosa after IV treatment (data
not shown). However, GFP-positive slides were observed after Ad-
MSCs were injected locally with the colonoscope and greater
numbers of GFP-positive slides were detected in rats treated with
Ad-MSCþ 1.5% Si-HPMC (Fig. 4A and B). Moreover, when GFP-
positive cells were detected on a slide, a greater amount of GFP
cells was observed in the colon of rats locally injected with Ad-
MSCs embedded in 1.5% Si-HPMC compared with rats locally
injected with cells alone (Fig. 4B, right graph). We observed that
one week after in vivo injection of Ad-MSCs embedded in 1.5% Si-
HPMC into chronic colonic damage, most of the cells were local-
ized at the periphery of the hydrogel and had a ﬁbroblastic-like
shape. After later time points (14 and 21 days after injection), Ad-
MSC GFP-positive cells were still observed only in the group Ad-
MSC þ hydrogel. Lower quantity of cells was observed and they
were fully protected by the hydrogel (Fig. 4C).
3.6. Fate of Ad-MSCs engrafted in irradiated colonic tissue
To analyze the behavior of locally injected Ad-MSCs in irradiated
tissue, we tested their proliferative capacity and whether detected
cells were apoptotic. Colorectal irradiation leads to a hostile
microenvironment with high oxidative stress, ischemia and
inﬂammation which could limit the viability of the injected cells.
The proliferation of Ad-MSCs in irradiated colonic tissue was
assessed using PCNA staining. One week after the injection, we
observed that the majority of the cells were not proliferating
independently in the presence of the hydrogel (Fig. 5A). TUNEL
staining was used to detect the cells that underwent programmed
cell death. In our experiments, we demonstrated that Ad-MSCs,
whether embedded or not in hydrogel, are not apoptotic (Fig. 5B)
(Data not shown for PCNA and TUNEL staining without hydrogel).
3.7. Si-HPMC-embedded Ad-MSC attenuates macrophage inﬁltrate
Macrophage inﬁltrate is persistent in late radiation colonic
damage. Macrophages are involved in tissue clearing and initiate
tissue remodeling after tissue injury, but they also play a role in
perpetuating inﬂammation. In this study, we investigated macro-
phage inﬁltrate using CD68 antigen immunostaining (Fig. 6). We
demonstrated that one week after injection of 1.5% Si-HPMC alone
in the irradiated mucosa, few CD68-positive cells were detected. A
greater amount of macrophages was detected near Ad-MSC-
implanted cells compared with Ad-MSCs embedded in Si-HPMC
(Fig. 6A and B).
To understand themechanism of action bywhich Ad-MSCsþ Si-
HPMC could decrease macrophage inﬁltrate, we questioned
whether the secretion of chemoattractant molecules by Ad-MSCs ismodiﬁed by their embedding in 1.5% Si-HPMC. Moreover, chronic
side effects induced after irradiation are associated with IL1b and
TGFb cytokine secretion. Therefore, we also tested the secretion
capacities of Ad-MSCs after these pro-inﬂammatory stimulations
retracing the in vivo situation. Using an ELISA assay, we demon-
strated that in the absence of stimulation, embedding cells in
hydrogel did not modify the chemoattractant secretion proﬁles
(Fig. 7A). However, when Ad-MSCs were stimulated with IL-1b and
TGF-b, as in an in vivo situation, it was shown that Ad-MSCs
secreted fewer chemoattractant molecules in 3D than in 2D
(Fig. 7A). Numerous studies demonstrated that Ad-MSCs secrete
anti-inﬂammatory molecules as well as high quantity of VEGF
molecule involved in pro-angiogenesis process. In this study, we
analyzed the modiﬁcations of these molecules following hydrogel-
Fig. 5. Fate of Ad-MSCþ1.5% Si-HPMC engrafted in irradiated colonic tissue 7 days after
injection. (A) Analyses of Ad-MSC proliferation. Representative pictures of serial slides
of GFP immunostaining (in blue, left picture) and PCNA immunostaining (in blue, right
picture). GFP-positive cells were localized in the center whereas PCNA immunostaining
at the periphery determining that few Ad-MSCs were proliferating in vivo when they
were injected in the hydrogel. (B) Analyses of Ad-MSC apoptosis using TUNEL assay.
Ad-MSCs are stained in red and apoptotic cells are stained in green. Cells stained in
yellow (dual stained red and green) upon analysis represent apoptotic cells. Repre-
sentative pictures of the positive control (cell death is induced by DNase treatment)
and irradiated rats injected with 1 million Ad-MSCs locally with the hydrogel (1.5%). No
yellow cells were detected determining that Ad-MSCs were not apoptotic in the
hydrogel. N ¼ 8 animals per group. IR ¼ irradiated rats, M ¼ million.
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secretion is increased in 3D conditions, however IL10 is not modi-
ﬁed after hydrogel embedding and Il1b þ TGFb stimulations. We
also demonstrated that stimulated Ad-MSCs secrete more VEGF in
3D compared with 2D conﬁguration (Fig. 7B).
4. Discussion
Intravenous injection of MSCs has been shown to improve the
intestinal regeneration process after irradiation [3,4,9,29]. The
reparative potential of MSCs has been shown to be mediated by the
release of a broad spectrum of soluble factors [8]. Systemic infusion
of MSCs has been promulgated as a simple, reproducible and safe
delivery strategy for use in clinics [7,18]. The ability of MSCs to host
injured tissues may result in localized therapeutic beneﬁts. How-
ever, the potential of MSC migration to the injured organs after
intravenous (IV) injection is impeded by cell trapping within the
lung [14]. Moreover, the optimal time-point for IV MSC delivery is
unknown and is dependent upon the secretion of chemoattractant
molecules like SDF1a [30]. In view of the uncertain fate of IV-
injected cells, local injection of MSCs, implanted directly into the
lesion site, which has been tested in different tissues [31,32], allows
fewer cells to be injected and provides a greater therapeutic beneﬁt
[31]. For the ﬁrst time, this study proposes and demonstrates the
feasibility of colonoscopy to deliver MSCs directly into the colon
without surgery, using imaging and syringe catheter systems.
However, once injected into the injured tissue the cell survival rate
could be limited due to the ischemic and inﬂammatory microen-
vironment induced after irradiation. Growing evidence suggests
that synthetic biomaterials are an encouraging approach to sus-
taining the long-term cell viability of stem cells in situ, by creating
an optimal niche that preserves the cells. These scaffolds offer the
potential to appropriately deliver cells into the injured site, opti-
mizing the therapeutic effect of stem cell therapy. Amongst the
biomaterials used in regenerativemedicine, hydrogels are likely the
most suitable materials since they display injectability and cross-
linking properties. We used a Si-HPMC hydrogel that displays
rheological properties appropriate to its implantation via mini-
invasive surgery [26]. The advantage of this hydrogel is its self-
setting property without any addition of cross-linking toxic
agents. It is a hydrophilic and neutral hydrogel with no bioactivity.
Its inﬂuence is to provide a protective barrier and to maintain the
cell in a non-adherent shape. It has already been demonstrated that
intra-myocardial delivery of MSC-embedded Si-HPMC preserves
cardiac function after myocardial infarction [22]. Intra-colonic in-
jection of Ad-MSCs has not yet been proposed as a pre-clinical
treatment for radiation-induced colorectal damage. In this study,
we established Si-HPMC with rheological properties that can be
loaded through the syringe catheter system of a colonoscope. The
gelation time of Si-HPMC has been determined to enable a cell-
hydrogel mixture as well as its injection in vivo. This time is suit-
able for manipulation in an operating theatre and could be used by
surgeons. Furthermore, we demonstrated that Ad-MSCs in Si-
HPMC are 95% viable for up to 21 days in vitro and are biologi-
cally active. Indeed, we determined that Ad-MSCs in 3D conﬁgu-
ration in 1.5% Si-HPMC displayed a round shape in vitro that has no
inﬂuence on their ability to secrete molecules involved in epithelial
regeneration, angiogenesis or the anti-inﬂammatory process.
MSCs from bone marrow have been used to treat radiation-
induced proctitis in patients over-irradiated at Epinal hospital. It
has been demonstrated that MSCs reduced pain and the number of
episodes of diarrhea in three patients who were resistant to
symptomatic treatments [6]. The aim of this study was to ﬁnd a
novel clinically-applicable procedure for MSC treatment of colo-
rectal damage that improves the therapeutic beneﬁt whilst at thesame time decreasing the number of injected cells. We used a rat
model of gastrointestinal complications following radiotherapy.
Patients treated for rectal adenocarcinoma with preoperative
radiotherapy receive a total dose of 45Gy, delivered in fraction of 1.8
or 2Gy. However, previous works performed in rats showed no
changes on colonic structure after fractionated irradiation [33].
Here, the irradiation methodology used is a single dose of 29 Gy
which induces severe colorectal damage similar to that observed in
patients subjected to radiotherapy [4]. We analyzed the structure
and intestinal permeability which is one of the primordial func-
tions of the gut epithelium and is commonly used as a marker of
epithelial integrity. Increased intestinal permeability has already
been demonstrated in rat ileum after 5Gy abdominal irradiation
[34,35]. This result has been conﬁrmed in patients affected by
breast cancer, sarcoma and colorectal cancer treated with different
chemotherapy agents or after radiotherapy [36e40]. In our rat
model of severe and chronic radiation-induced damage [3], we
demonstrated an alteration of the colonic histological structure
associated with an increase in epithelial permeability of colon/
rectum segments to FD4 and HRP macromolecules 4 weeks after
irradiation. These data are of particular importance, and demon-
strate the clinical relevance of our animal model, since the colon
delivers a plentiful source of luminal antigens within the range of
molecular weights herein assessed, which may generate mucosal
injury and be a reservoir of systemic infections [41].
This study conﬁrmed previous results demonstrating the ther-
apeutic beneﬁt of 5 million IV-injected Ad-MSCs on epithelial
structure after localized irradiation [5]. A decrease in the number of
cells (1 million), whether IV- or locally-injected, has no therapeutic
Fig. 6. Macrophage inﬁltrate near implanted Ad-MSCs. (A) Representative pictures of serial slides of GFP immunostaining (in blue, top pictures) and CD68 immunostaining (in blue,
bottom pictures) 7 days after injection. Squares in the bottom pictures represent an enlargement of the areas after CD68 immunostaining. CD68 imunostaining is more important
when Ad-MSCs were injected alone (bottom middle picture) in comparison with Ad-MSCs embedded in Si-HPMC (bottom right picture). (B) Quantiﬁcation of CD68 inﬁltrate, the
surface of CD68 staining is evaluated among 10 000m2 of tissue surface. N ¼ 8 animals per group. IR ¼ irradiated rats, M ¼million, loc ¼ locally injected cells. xp < 0.05 vs. irradiated
rats locally injected with Ad-MSCs without hydrogel, xxp < 0.01 vs. irradiated rats locally injected with Ad-MSCs without hydrogel.
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produced no improvement in epithelial structure. This result can
be explained by our in-vitro observations demonstrating that the
rheological properties of 1% Si-HPMC do not allow entrapment of
all the cells since some cells remain attached to the culture dish and
are not inside the hydrogel. However, Ad-MSCs embedded in 1.5%
Si-HPMC statistically improved all the parameters tested in this
study. This therapeutic beneﬁt is associated with an increase in Ad-
MSC engraftment in the colonic mucosa compared to all other
groups. Different therapeutic effects have been proposed for MSCs,
but it is now well established that the paracrine effect is the most
prevalent rather than differentiation or transdifferentiation in
epithelial cells [42,43]. They have been shown to act therapeutically
by releasing pro-regenerative factors and/or by modulating the
immune response through several factors [44]. Thus, increasing Ad-
MSC engraftment could help improve their therapeutic beneﬁt.
Moreover, we determined that 7 days after in vivo injection in the
irradiated colonic mucosa, Ad-MSCs embedded in 1.5% hydrogel
were not apoptotic. It could be hypothesized that 1.5% Si-HPMC
preserves the cells at various levels. It has been reported that the
cells are protected from mechanical forces, by the hydrogel, during
syringe needle ﬂow [45]. This result suggests that cells could be
protected by Si-HPMC in the early stages of the treatment process.
Moreover, when Ad-MSCs were recovered after culture expansion,
then injected in saline solution into the tissue, their lack of adhe-
sion to extracellular matrix can promote apoptotic signaling. 1.5%
Si-HPMC could therefore be an appropriate scaffold tomaintain cell
viability within the tissue and derive a therapeutic beneﬁt. Indeed,
strategies using genetically-modiﬁed MSCs to decrease theirapoptosis have been successfully applied in animal models [46,47].
These interesting experiments shed light on the correlation be-
tween the therapeutic beneﬁt and the inhibition of MSC apoptosis.
However, their use in clinics cannot be applied at present. Another
hypothesis is that 1.5% Si-HPMC could protect the cells from the
inﬂammatory environment induced after irradiation. It has been
demonstrated that irradiation induces chronic secretion of pro-
inﬂammatory molecules as IL1b and TGFb [19,48] and reactive
oxygen species [49]. However, it has been observed that molecules
are able to diffuse through the scaffold. Therefore under these
conditions, we observed a statistical increase in VEGF secretion in
3D after stimulation with IL1b and TGFb. It is therefore likely that
Ad-MSCs in 1.5% Si-HPMC are able to resist the inﬂammatory
environment. Indeed, MSCs have been shown to resist irradiation
due to their high antioxidant capacities [50]. Moreover, it is now
acknowledged that the inﬂammatory environment to which MSCs
are exposed plays a pivotal role in activating their immunosup-
pressive functions [51]. Asmacrophage inﬁltrate is persistent in late
radiation colonic damage [19,20], our analyses focused on this type
of innate immune cells. We observed that high inﬁltration of
macrophages was seen in the vicinity of Ad-MSCs that were not
embedded within the hydrogel. Interestingly, there were fewer
CD68þ macrophages near Ad-MSCs embedded in 1.5% Si-HPMC.
This observation led us to hypothesize that Ad-MSCs were recog-
nized by host macrophages in a non-consanguinous situation. This
fact has also been observed in another study [52] and various hy-
potheses could be made. It has been argued that the culture
expansion modiﬁed membrane protein expression of MSCs,
particularly with modiﬁcation of HLA membrane expression,
Fig. 7. Secretion factors of Ad-MSCs in Si-HPMC compared with two-dimensional Ad-MSCs. (A) Graphs represent the chemokine contents of the supernatant of Ad-MSCs
stimulated or not with IL1b and TGFb. Ad-MSCs stimulated with IL1b and TGFb secreted less chemoattractants compared with Ad-MSCs embedded in 1.5% Si-HPMC. (B) Graphs
represent PGE2 and IL10 (anti-inﬂammatory) and VEGF (pro-angiogenic) contents of the supernatant of Ad-MSCs stimulated or not with IL1b and TGFb. All the results were
normalized by DNA quantiﬁcation. N ¼ 3 donors in triplicate. *p < 0.05, **p < 0.01.
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explanation is the initialization of tissue clearing by macrophages
in the presence of a huge amount of exogenous cells in the tissue
structure. Indeed, it has been demonstrated that autologous MSCs
injected in immune-deﬁcient mice lacking T, B and NK cells have a
short survival time [15], indicating that other cell types, like mac-
rophages, could contribute to the clearance of MSCs. Interestingly,
our results demonstrated limited macrophage inﬁltrate near the
hydrogel-embedded Ad-MSCs. This result is of particular impor-
tance since 1.5% Si-HPMC seems to protect Ad-MSCs from the
macrophages. In the context of a clinical application, it will be
interesting to test whether the same result is observed with Ad-
MSCs from other strains embedded in Si-HPMC.
To understand the molecular mechanism of macrophage inﬁl-
tration modulation, we analyzed the secretion of chemoattractant
molecules by Ad-MSCs, in a native context or stimulated by IL1b
and TGFb which are secreted in colonic mucosa after irradiation.
We observed that the secretion of IL-8 and MCP-1 in particular, is
higher in non-entrapped cells than in Ad-MSCs in 3D after stimu-
lation with IL1b and TGFb. These results suggest a modiﬁcation of
the phenotype of Si-HPMC-embedded MSC compared to cells in
culture plastic ﬂask. Various studies already demonstrated a
modiﬁcation of secretion abilities when the cells are in 3D
compared with cells cultured in monolayer [21,55,56]. Moreover, it
has also been suggested that 3D culture conditions are closest of the
in vivo environment compared with the simplicity of 2D culture
that seems a reductionist approaches to understand thephysiological behavior of cells [57]. Besides, a recent study
demonstrated that topographical cues inﬂuence the soluble factors
secreted by MSCs and modify the communication between MSCs
and macrophages [56]. Similarly, Swartzlander et al. have demon-
strated that MSCs embedded in synthetic hydrogel were able to
attenuate macrophage activation [58]. These ﬁndings are of great
importance and suggest that MSCs may be able to combat foreign
body response (FBR) via macrophage cross-talk, the primary or-
chestrators of FBR [59]. Altogether, these data could explain our
in vivo observations, highlighting a decrease in CD68þmacrophages
near the hydrogel embedded with Ad-MSCs compared with Ad-
MSCs alone. Our results suggest that the hydrogel exerts an
immunoprotective function through two mechanisms: a decrease
in macrophage chemoattractant secretion by embedded cells in a
pro-inﬂammatory context and a delay in the tissue clearance of Ad-
MSCs trapped in the hydrogel.
In conclusion, we developed a Si-HPMC with rheological
properties compatible with injection through a colonoscope cath-
eter. The deﬁned properties are compatible with use by surgeons in
an operating theatre. We demonstrated that Ad-MSCs embedded in
1.5% Si-HPMC are biologically active in normal conditions and are
also able to modulate their secretome according to the inﬂamma-
tory context. Using a clinically-relevant animal model, we deter-
mined that local injection of 1 million Ad-MSCs embedded in 1.5%
Si-HPMC hydrogel improves the structure of colonic mucosa
damaged after irradiation. Ad-MSCs injected according to this
protocol have a greater therapeutic beneﬁt on colonic function
L. Moussa et al. / Biomaterials 115 (2017) 40e52 51measured by epithelial permeability compared with the intrave-
nous injection of Ad-MSCs which is the protocol currently used in
clinics. This therapeutic beneﬁt is associated with increased
engraftment of viable Ad-MSCs in the colonic submucosa. This
study also shows, for the ﬁrst time, that Ad-MSCs embedded in 1.5%
Si-HPMC are able to reduce macrophage inﬁltration in vivo near the
injection point. This innovative procedure produces encouraging
results and may represent a breakthrough in the use of stem cell-
assisted biomaterial therapy. This approach will allow a mini-
invasive intervention and could be proposed to patients suffering
from late radiotherapy side effects.
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